Migraine treatment in thailand: what helps and hinders eptinezumab use?
NCT ID NCT07035197
First seen Apr 14, 2026 · Last updated Jun 23, 2026 · Updated 13 times
Summary
This study looked at how migraine patients and healthcare providers in Thailand experience eptinezumab, a preventive migraine infusion given every 3 months. Researchers interviewed 30 participants to find out what makes it easier or harder to use this treatment in a real-world hospital setting. The goal is to improve migraine care and access to new therapies in middle-income countries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
King Chualongkorn Memorial Hospital, the Thai Red Cross Society
Bangkok, 10330, Thailand
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
eptinezumab
What this could lead to
If successful, this study could help improve access to eptinezumab for migraine patients in Thailand and similar countries.
What could go wrong
This is a small, completed observational study (30 participants) that gathers opinions and experiences, not a large trial testing effectiveness. Results may not apply to other settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.